Therefore, we investigated in the present study the possible anti-epileptic effect of liraglutide (GLP-1R agonist) against PTZ kindled epilepsy and its possible underlying mechanisms by targeting autophagy, apoptosis, oxidative stress and the Wnt pathway. Here, GLP1R is linked to epilepsy.